Bacon Bruce R
Am J Gastroenterol. 2004 Sep;99(9):1706-7. doi: 10.1111/j.1572-0241.2004.40627.x.
Improvements in the treatment of patients with chronic hepatitis C have progressed over the past 14 yr. Initially, treatment of patients with persistently normal ALT levels was not considered necessary. As treatment response improved, more of these patients were treated. Jacobson and colleagues have shown that patients with normal ALT levels respond similarly to those with elevated ALT levels when treated with the combination of interferon and ribavirin. ALT levels are a poor marker of disease severity and/or indication for treatment in patients with chronic hepatitis C.
在过去14年中,慢性丙型肝炎患者的治疗取得了进展。最初,人们认为对丙氨酸氨基转移酶(ALT)水平持续正常的患者进行治疗没有必要。随着治疗反应的改善,越来越多这类患者接受了治疗。雅各布森及其同事已经表明,当使用干扰素和利巴韦林联合治疗时,ALT水平正常的患者与ALT水平升高的患者反应相似。ALT水平并不是慢性丙型肝炎患者疾病严重程度和/或治疗指征的良好指标。